Rocket Pharmaceuticals, Inc.
DE ˙ DB ˙ US77313F1066
2,44 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:9IP1 / Rocket Pharmaceuticals, Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership623,354 shares
Latest Disclosed Value $ 2,231,607
Jane Street Group, Llc ownership in 9IP1 / Rocket Pharmaceuticals, Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 623,354 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $1,754,742 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 602,580 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of 3.45% during the quarter. The current value of the position is $1,520,984 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (9IP1) in the form of stock options. The firm currently holds call options representing 21,800 of underlying shares valued at $78,044 USD and put options representing 12,600 of underlying shares valued at $45,108 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9IP1 / Rocket Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 623,354 20,774 3.45 2,232 5.48 0.0001
2026-02-12 2025-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 602,580 118,099 24.38 2,115 33.95 0.0003
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 484,481 440,213 994.43 1,579 1,362.04 0.0002
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 44,268 -2,320 -4.98 108 -65.16 0.0000
2025-05-19 2025-03-31 13F/A-1 ROCKET PHARMACEUTICALS COM 77313F106 46,588 6,214 15.39 311 -38.86 0.0001
2025-05-14 2025-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 46,588 6,214 311 0.0001
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 40,374 -137,298 -77.28 508 -84.55 0.0001
2024-11-15 2024-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 177,672 47,134 36.11 3,282 16.76 0.0007
2024-08-15 2024-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 130,538 130,538 2,810 0.0006
2024-05-16 2024-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -48,048 -100.00 0 -100.00
2024-02-15 2023-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 48,048 12,353 34.61 1,440 96.85 0.0004
2023-11-15 2023-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 35,695 -101,146 -73.91 731 -73.12 0.0002
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 136,841 112,289 457.35 2,719 547.38 0.0009
2023-05-16 2023-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 24,552 8,099 49.23 421 30.84 0.0002
2023-02-15 2022-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 16,453 5,107 45.01 322 77.35 0.0001
2022-11-15 2022-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 11,346 -1,650 -12.70 181 1.12 0.0001
2022-08-16 2022-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 12,996 12,996 179 0.0001
2022-05-17 2022-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 0 -10,925 -100.00 0 -100.00
2022-02-15 2021-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 10,925 660 6.43 239 -22.15 0.0001
2021-11-16 2021-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 10,265 5,377 110.00 307 42.13 0.0001
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM 77313F106 4,888 -14,329 -74.56 216 -74.68 0.0001
2021-05-18 2021-03-31 13F ROCKET PHARMACEUTICALS COM 77313F106 19,217 -1,518 -7.32 853 -24.98 0.0004
2021-02-17 2020-12-31 13F ROCKET PHARMACEUTICALS COM 77313F106 20,735 882 4.44 1,137 150.44 0.0006
2020-11-17 2020-09-30 13F ROCKET PHARMACEUTICALS COM 77313F106 19,853 19,853 454 0.0003
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F ROCKET PHARMACEUTICALS COM Call 21,800 78 n/a n/a n/a
2026-02-12 2025-12-31 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM Call 68,900 -2.27 225 30.23 n/a n/a n/a
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM Call 70,500 400.00 173 82.98 n/a n/a n/a
2025-05-19 2025-03-31 13F/A ROCKET PHARMACEUTICALS COM Call 14,100 94 n/a n/a n/a
2025-05-14 2025-03-31 13F ROCKET PHARMACEUTICALS COM Call 14,100 94 n/a n/a n/a
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F ROCKET PHARMACEUTICALS COM Call 10,900 -89.02 201 -90.59 n/a n/a n/a
2024-08-15 2024-06-30 13F ROCKET PHARMACEUTICALS COM Call 99,300 70.91 2,138 36.55 n/a n/a n/a
2024-05-16 2024-03-31 13F ROCKET PHARMACEUTICALS COM Call 58,100 -85.51 1,565 -86.98 n/a n/a n/a
2024-02-15 2023-12-31 13F ROCKET PHARMACEUTICALS COM Call 401,000 4.37 12,018 52.65 n/a n/a n/a
2023-11-15 2023-09-30 13F ROCKET PHARMACEUTICALS COM Call 384,200 361.22 7,872 375.65 n/a n/a n/a
2023-08-14 2023-06-30 13F ROCKET PHARMACEUTICALS COM Call 83,300 1.22 1,655 17.46 n/a n/a n/a
2023-05-16 2023-03-31 13F ROCKET PHARMACEUTICALS COM Call 82,300 445.03 1,410 377.63 n/a n/a n/a
2023-02-15 2022-12-31 13F ROCKET PHARMACEUTICALS COM Call 15,100 -47.93 296 -36.29 n/a n/a n/a
2022-11-15 2022-09-30 13F ROCKET PHARMACEUTICALS COM Call 29,000 104.23 463 137.44 n/a n/a n/a
2022-08-16 2022-06-30 13F ROCKET PHARMACEUTICALS COM Call 14,200 195 n/a n/a n/a
2022-02-15 2021-12-31 13F ROCKET PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-16 2021-09-30 13F ROCKET PHARMACEUTICALS COM Call 26,900 -29.95 804 -52.73 n/a n/a n/a
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM Call 38,400 1,701 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F ROCKET PHARMACEUTICALS COM Put 12,600 45 n/a n/a n/a
2026-02-12 2025-12-31 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F ROCKET PHARMACEUTICALS COM Put 45,700 13.40 149 51.02 n/a n/a n/a
2025-08-14 2025-06-30 13F ROCKET PHARMACEUTICALS COM Put 40,300 99 n/a n/a n/a
2025-02-14 2024-12-31 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-15 2024-09-30 13F ROCKET PHARMACEUTICALS COM Put 10,200 -24.44 188 -35.17 n/a n/a n/a
2024-08-15 2024-06-30 13F ROCKET PHARMACEUTICALS COM Put 13,500 14.41 291 -8.52 n/a n/a n/a
2024-05-16 2024-03-31 13F ROCKET PHARMACEUTICALS COM Put 11,800 -94.66 318 -95.21 n/a n/a n/a
2024-02-15 2023-12-31 13F ROCKET PHARMACEUTICALS COM Put 221,000 -11.71 6,623 29.15 n/a n/a n/a
2023-11-15 2023-09-30 13F ROCKET PHARMACEUTICALS COM Put 250,300 5,129 n/a n/a n/a
2023-02-15 2022-12-31 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-15 2022-09-30 13F ROCKET PHARMACEUTICALS COM Put 19,300 2.66 308 18.92 n/a n/a n/a
2022-08-16 2022-06-30 13F ROCKET PHARMACEUTICALS COM Put 18,800 259 n/a n/a n/a
2021-08-16 2021-06-30 13F ROCKET PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-18 2021-03-31 13F ROCKET PHARMACEUTICALS COM Put 7,600 -42.42 337 -53.45 n/a n/a n/a
2021-02-17 2020-12-31 13F ROCKET PHARMACEUTICALS COM Put 13,200 724 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.